Confo Therapeutics
PrivateLast Round
Series B
Jul 26, 2024
Total Funding Raised
$115.57M
Company Overview
Confo Therapeutics is a biotechnology company that develops novel GPCR-directed medicines for metabolic and endocrine diseases using its proprietary Confo® technology platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Confo Therapeutics Comparables
Compare Confo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Domain Therapeutics | 81% | |
| Nxera Pharma | 80% | |
| leadXpro AG | 80% | |
Confo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 26, 2024 | ||||
| Grant | Mar 28, 2024 | ||||
| Grant | Jun 28, 2022 | ||||
| Grant | Mar 30, 2021 | ||||
| Grant | Jun 20, 2019 | ||||
Series A | May 7, 2019 |
Key People
Founding team and executive leadership
Confo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Series B |
| Capricorn Partners | Series B, Seed |
| Perceptive Advisors | Series A, Series B |
| Fund+ | Series A, Series B |
| Capricorn Health-tech Fund | Series A, Seed, Series B |
| V-Bio Ventures | Series A, Seed, Series B |
| VLAIO | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 39% MoM, reaching 7.9K.
- Jul 26, 2024
$65M round led by Ackermans & van Haaren.
Confo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Confo Therapeutics's valuation, stock price, and market status.